These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22846184)

  • 1. Non-small-cell lung carcinoma subtyping on cytology without the use of immunohistochemistry - can we meet the challenge?
    Manucha V; Wang C; Huang Y
    Acta Cytol; 2012; 56(4):413-8. PubMed ID: 22846184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach.
    Bishop JA; Benjamin H; Cholakh H; Chajut A; Clark DP; Westra WH
    Clin Cancer Res; 2010 Jan; 16(2):610-9. PubMed ID: 20068099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal combination of immunohistochemical markers for subclassification of non-small cell lung carcinomas: A tissue microarray study of poorly differentiated areas.
    Noh S; Shim H
    Lung Cancer; 2012 Apr; 76(1):51-5. PubMed ID: 21978426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyto-histologic agreement in pathologic subtyping of non small cell lung carcinoma: review of 602 fine needle aspirates with follow-up surgical specimens over a nine year period and analysis of factors underlying failure to subtype.
    da Cunha Santos G; Lai SW; Saieg MA; Geddie WR; Pintilie M; Tsao MS; Boerner SL; Hwang D
    Lung Cancer; 2012 Sep; 77(3):501-6. PubMed ID: 22656670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6.
    Mukhopadhyay S; Katzenstein AL
    Am J Surg Pathol; 2011 Jan; 35(1):15-25. PubMed ID: 21164283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subclassification of non-small cell lung cancer by cytologic sampling: a logical approach with selective use of immunocytochemistry.
    Kimbrell HZ; Gustafson KS; Huang M; Ehya H
    Acta Cytol; 2012; 56(4):419-24. PubMed ID: 22846197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Napsin A/p40 antibody cocktail for subtyping non-small cell lung carcinoma on cytology and small biopsy specimens.
    Nishino M; Hoang MP; Della Pelle P; Morales-Oyarvide V; Huynh TG; Mark EJ; Mino-Kenudson M
    Cancer Cytopathol; 2016 Jul; 124(7):472-84. PubMed ID: 27412420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A reevaluation of the clinical significance of histological subtyping of non--small-cell lung carcinoma: diagnostic algorithms in the era of personalized treatments.
    Rossi G; Pelosi G; Graziano P; Barbareschi M; Papotti M
    Int J Surg Pathol; 2009 Jun; 17(3):206-18. PubMed ID: 19443885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic findings of bronchial brush cytology for pulmonary large cell neuroendocrine carcinomas: comparison with poorly differentiated adenocarcinomas, squamous cell carcinomas, and small cell carcinomas.
    Kakinuma H; Mikami T; Iwabuchi K; Yokoyama M; Hattori M; Ohno E; Kuramoto H; Jiang SX; Okayasu I
    Cancer; 2003 Aug; 99(4):247-54. PubMed ID: 12925987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reliability of cytologic diagnosis of early lung cancer.
    Vazquez MF; Koizumi JH; Henschke CI; Yankelevitz DF
    Cancer; 2007 Aug; 111(4):252-8. PubMed ID: 17614298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bronchoscopic and transthoracic cytology and biopsy for pulmonary nonsmall cell carcinomas: performance characteristics by procedure and tumor type.
    Tochigi N; Dacic S; Ohori NP
    Diagn Cytopathol; 2012 Aug; 40(8):659-63. PubMed ID: 21319328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein expression profiles of non-small cell lung carcinomas: correlation with histological subtype.
    Volm M; Koomägi R; Efferth T; Mattern J
    Anticancer Res; 2002; 22(4):2321-4. PubMed ID: 12174921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subtyping of non-small cell lung carcinoma: a comparison of small biopsy and cytology specimens.
    Sigel CS; Moreira AL; Travis WD; Zakowski MF; Thornton RH; Riely GJ; Rekhtman N
    J Thorac Oncol; 2011 Nov; 6(11):1849-56. PubMed ID: 21841504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of p63 as an effective immunomarker in the diagnosis of pulmonary squamous cell carcinomas on de-stained bronchial lavage cytological smears.
    Uke M; Rekhi B; Ajit D; Jambhekar NA
    Cytopathology; 2010 Feb; 21(1):56-63. PubMed ID: 19744186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive immunohistochemistry algorithm for the histological subtyping of small biopsies obtained from non-small cell lung cancers.
    Koh J; Go H; Kim MY; Jeon YK; Chung JH; Chung DH
    Histopathology; 2014 Dec; 65(6):868-78. PubMed ID: 25130792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlations between the results of the histological and cytological examination in the diagnostic of the broncho-pulmonary cancer.
    Drăgan AM; Roşca E; Vaida T
    Rom J Morphol Embryol; 2005; 46(4):311-5. PubMed ID: 16688369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of cytology in the diagnostics of lung cancer.
    Berg J; Aase S; Søland TH; Gabrielsen AM; Svendsen MV; Lien JT; Hauss G
    APMIS; 2005 Mar; 113(3):208-12. PubMed ID: 15799765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of cytological diagnosis of small cell lung carcinoma.
    Domagała-Kulawik J; Górnicka B; Krenke R; Mich S; Chazan R
    Pneumonol Alergol Pol; 2010; 78(3):203-10. PubMed ID: 20461688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of adjunct immunohistochemistry on reporting patterns of non-small cell lung carcinoma diagnosed histologically in a regional pathology centre.
    McLean EC; Monaghan H; Salter DM; Wallace WA
    J Clin Pathol; 2011 Dec; 64(12):1136-8. PubMed ID: 21606231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What's new in non-small cell lung cancer for pathologists: the importance of accurate subtyping, EGFR mutations and ALK rearrangements.
    Cooper WA; O'toole S; Boyer M; Horvath L; Mahar A
    Pathology; 2011 Feb; 43(2):103-15. PubMed ID: 21233671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.